Table 2.
Completed and ongoing clinical trials on the effects of curcumin in prostate cancer.
| Intervention | Study | Status | Identifier Number/ Reference |
|---|---|---|---|
| Curcumin | Effects on PCa patients that undergo intermittent androgen deprivation (IAD) | Completed |
NCT03211104/ [66] |
| Curcumin, Docetaxel & Prednisone |
Combination with standard chemotherapy agents, docetaxel and prednisone in patients with castration-resistance PCa | Completed | *[286] |
| Curcumin | Radiosensitizing and radioprotective effects in PCa patients | Completed |
NCT01917890/ [287] |
| Curcumin & Isoflavones |
Combination with isoflavones who had prostate biopsy due to elevated PSA levels but do not have PCa | Completed | * [290] |
| Curcumin | Adjuvant use of curcumin after prostatectomy in improving recurrence-free survival for PCa patients | Recruiting |
NCT02064673/ [291] |
| Curcumin | Effects on prevention progression of low-risk PCa under active surveillance | Recruiting |
NCT03769766/ [292] |
* NCT number National Clinical Trial (NCT) Identifier not shown.